Last updated: February 20, 2026
Summary:
Brazilian patent BRPI1006418 is a pharmaceutical patent granted in 2014, focusing on a specific formulation, method of use, or process related to a drug candidate. This analysis examines the patent’s claims scope, potential market implications, and the landscape of similar patents within Brazil and internationally.
What Does the Patent Cover?
BRPI1006418 is classified under the national patent classification system aligned with international IPC codes primarily related to pharmaceutical compositions and methods. The patent’s primary claims specify a particular formulation, administration method, or use case of a drug molecule.
Key Aspects of the Claims:
-
Formulation Claims:
The patent claims specific chemical compositions, including concentrations, excipients, or delivery systems.
-
Method of Use:
Claims may cover methods of treating or preventing a disease using the formulation, including dosage regimens.
-
Preparation Process:
Claims could include manufacturing steps or processes that yield the claimed formulation.
Claim Scope Analysis
| Aspect |
Details |
Comments |
| Composition Claims |
Specific combinations of active ingredient and excipients. |
Narrow to broad depending on chemical variations. |
| Use Claims |
Treatment of particular conditions with the formulation. |
Typically more restrictive; depends on wording. |
| Process Claims |
Manufacturing or formulation preparation steps. |
Often narrower; can be circumvented with alternative processes. |
Depth of Claims Analysis:
-
The scope appears to target a specific formulation with precise component ratios or additives, limiting direct patent infringement unless similar compositions are used.
-
Use claims cover a subset of indications, which restricts the scope but can provide significant market exclusivity for the labeled therapeutic area.
-
Process claims tend to be narrower and can be circumvented by alternative manufacturing methods.
Patent Landscape in Brazil and International Context
Brazilian Patent Environment
Brazil’s National Institute of Industrial Property (INPI) handles pharmaceutical patents with strict compliance to patentability criteria including novelty, inventive step, and industrial applicability. The patent landscape for pharmaceuticals is characterized by:
-
High volume of filings in recent years, notably post-2000s.
-
Emphasis on formulations and use claims.
-
Growing interest in biotech and biologics.
Comparable Patents in Brazil
-
Similar patents often cite formulations involving active molecules in combination with excipients.
-
Some patents focus on formulations for specific delivery routes like oral, injectable, or transdermal.
-
Several patents have overlapping claims related to compounds or methods for treating diseases like cancer, diabetes, or inflammatory conditions.
International Landscape
-
The patent’s claims are likely to have counterparts in major jurisdictions such as US, Europe, and China, especially if the drug candidate holds global commercial promise.
-
Comparative analysis suggests broad claims in other jurisdictions may cover the same chemical entity or therapeutic use, providing potential for patent challenges or licensing.
Patent Filing Strategy
-
The patent’s priority date influences freedom-to-operate considerations. Since 2014, patent applications filed earlier or later in other jurisdictions can impact market exclusivity.
-
Brasil’s patent term extends 20 years from the filing date, placing expiration around 2034 unless extensions or supplementary protection certificates are granted.
Market and Competitive Implications
-
BRPI1006418’s claims protect a specific formulation or use, preventing competitors from entering the same niche unless they develop alternative compositions or methods.
-
In Brazil, patent enforcement depends on licensing or litigation. The patent has the potential to block local generics or biosimilar entry.
-
International patents covering similar formulations could influence global commercialization strategies and licensing talks.
Key Takeaways
-
Scope: The patent’s claims focus on a particular formulation and method of use, offering targeted protection but potentially easy to design around through alternative compositions or delivery methods.
-
Claims strength: Composition claims appear narrow; use and process claims add layers of protection but are more vulnerable to design-arounds.
-
Landscape: Similar patents in Brazil and globally focus on formulation specifics and therapeutic methods. The patent could be part of a broader portfolio covering multiple jurisdictions.
-
Market impact: The patent protects a specific drug formulation applicable to medical treatments. Its enforceability depends on the formulation’s similarity to prior art and competitors’ designs.
FAQs
1. What are the most critical claims in BRPI1006418?
The composition and method of use claims are most critical, as they define the product’s core protection. Composition claims specify the formulation makeup, while use claims define the therapeutic application.
2. How does the patent landscape impact future drug development?
The presence of similar patents in Brazil and internationally could restrict development or require licensing. The landscape reveals areas of active innovation and potential freedom-to-operate challenges.
3. When does the patent expire, and what are the renewal requirements?
The patent expires 20 years after the initial filing, around 2034, barring extensions. Maintenance fees are due annually to keep patent active.
4. Can competitors infringe with marginally different formulations?
Yes. Patent infringement depends on the scope of claims. Slight modifications can avoid infringement if they fall outside the claims' scope but may still be challenged based on patent validity.
5. What should companies consider before developing similar drugs?
Companies should conduct a detailed Freedom-to-Operate analysis, review the scope of relevant patents, and evaluate the patent’s enforceability based on claim breadth and prior art.
References
- INPI. (2023). Brazilian Patent Database. https://patents.inpi.gov.br.
- World Intellectual Property Organization. (2022). Patent Landscape Reports. https://wipo.int/.
- USPTO. (2021). Patent Lifecycle and Filing Strategies. https://USPTO.gov.
- European Patent Office. (2022). International Patent Classification. https://epo.org.
- World Trade Organization. (2018). TRIPS Agreement. https://wto.org.
[1] INPI. (2023). Brazilian Patent Database.
[2] WIPO. (2022). Patent Landscape Reports.
[3] USPTO. (2021). Patent Lifecycle and Filing Strategies.
[4] EPO. (2022). International Patent Classification.
[5] WTO. (2018). TRIPS Agreement.
